President Trump announced a controversial recommendation to limit the use of acetaminophen, the active ingredient in Tylenol, during pregnancy, citing potential links to autism. This announcement was made during a White House event where he outlined a new approach to autism treatment. The FDA plans to recommend that pregnant women use acetaminophen only when necessary and at the lowest effective dose. Additionally, the administration will make leucovorin, a drug previously used in cancer treatment, available for children with autism symptoms. Experts have raised concerns about the lack of scientific consensus on the link between acetaminophen and autism, warning that the administration's stance may mislead families seeking effective treatments. Critics emphasize the importance of established interventions like behavioral therapy over unproven medications. The FDA's actions come amid ongoing debates about autism's origins and treatment options.